NCT06260072View on ClinicalTrials.gov

Magnesium and Riboflavin Treatment for Post-Concussion Headache

PHASE2RecruitingINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Concussion, Intermediate
Interventions
DRUG

magnesium and riboflavin supplement

Five capsules considered one dose of the intervention (one 400 mg magnesium capsule and four 100 mg riboflavin capsules)

Trial Locations (1)

22903

RECRUITING

University of Virginia Student Health and Wellness Center, Charlottesville

All Listed Sponsors
lead

University of Virginia

OTHER